Chemoinformaics analysis of Petroselaidic acid
| Molecular Weight | 282.468 | nRot | 15 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 21 |
| Exact Molecular Weight | 282.256 | nRing | 0 |
| Solubility: LogS | -3.247 | nHRing | 0 |
| Solubility: LogP | 2.082 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 54.335 |
| nHD | 1 | BPOL | 34.977 |
| QED | 0.291 |
| Synth | 5.594 |
| Natural Product Likeliness | 3.133 |
| NR-PPAR-gamma | 0.244 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.044 |
| HIA | 0.835 |
| CACO-2 | -4.922 |
| MDCK | 0.00000897 |
| BBB | 0.925 |
| PPB | 0.828364 |
| VDSS | 1.097 |
| FU | 0.0972706 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.217 |
| CYP2c19-inh | 0.003 |
| CYP2c19-sub | 0.846 |
| CYP2c9-inh | 0.018 |
| CYP2c9-sub | 0.19 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.097 |
| CYP3a4-inh | 0.103 |
| CYP3a4-sub | 0.865 |
| CL | 3.477 |
| T12 | 0.171 |
| hERG | 0.046 |
| Ames | 0.09 |
| ROA | 0.832 |
| SkinSen | 0.038 |
| Carcinogencity | 0.027 |
| EI | 0.008 |
| Respiratory | 0.68 |
| NR-Aromatase | 0.689 |
| Antiviral | Yes |
| Prediction | 0.576912 |